CASTLE BIOSCIENCES, INC. Operating Expenses
CASTLE BIOSCIENCES, INC. (CSTL) reported Operating Expenses of $24.07 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2021-05-10
- CASTLE BIOSCIENCES, INC. operating expenses for the quarter ending 2021-03-31 was $24.07M, a 72.03% increase year-over-year.
- CASTLE BIOSCIENCES, INC. operating expenses for the quarter ending 2020-03-31 was $13.99M, a 88.03% increase year-over-year.
- CASTLE BIOSCIENCES, INC. operating expenses for the quarter ending 2019-12-31 was $13.01M, a 145.37% increase year-over-year.
- CASTLE BIOSCIENCES, INC. operating expenses for the quarter ending 2019-09-30 was $8.64M, a 65.69% increase year-over-year.
- CASTLE BIOSCIENCES, INC. operating expenses for fiscal 2019 was $37.23M, a 74.57% increase from fiscal 2018.
- CASTLE BIOSCIENCES, INC. operating expenses for fiscal 2018 was $21.32M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2021-03-31 | $24.07M 10-Q · filed 2021-05-10 | |||
| 2020-03-31 | $13.99M 10-Q · filed 2021-05-10 | $27.00M derived: sum of 2 quarters · filed 2021-05-10 | $35.64M derived: sum of 3 quarters · filed 2021-05-10 | $43.78M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $13.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $21.65M derived: sum of 2 quarters · filed 2020-03-10 | $29.79M derived: sum of 3 quarters · filed 2020-03-10 | $37.23M 10-K · filed 2020-03-10 |
| 2019-09-30 | $8.64M 10-Q · filed 2019-11-12 | $16.78M derived: sum of 2 quarters · filed 2019-11-12 | $24.22M 10-Q · filed 2019-11-12 | $29.52M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-06-30 | $8.14M 10-Q · filed 2019-09-03 | $15.58M 10-Q · filed 2019-09-03 | $20.88M derived: sum of 3 quarters · filed 2020-05-11 | $26.09M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-03-31 | $7.44M 10-Q · filed 2020-05-11 | $12.74M derived: sum of 2 quarters · filed 2020-05-11 | $17.96M derived: sum of 3 quarters · filed 2020-05-11 | $23.28M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $10.52M derived: sum of 2 quarters · filed 2020-03-10 | $15.83M derived: sum of 3 quarters · filed 2020-03-10 | $21.32M 10-K · filed 2020-03-10 |
| 2018-09-30 | $5.21M 10-Q · filed 2019-11-12 | $10.53M derived: sum of 2 quarters · filed 2019-11-12 | $16.02M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $5.32M 10-Q · filed 2019-09-03 | $10.81M 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |